載入...
Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma
The purpose of this study was to define the maximum tolerated dose of erlotinib and characterize its pharmacokinetics and safety profile, alone and with temozolomide, with and without enzyme-inducing antiepileptic drugs (EIAEDs), in patients with malignant gliomas. Patients with stable or progressiv...
Na minha lista:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Duke University Press
2006
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1871925/ https://ncbi.nlm.nih.gov/pubmed/16443950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/S1522851705000451 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|